DrugTargetBench
An Environment for Therapeutic Target Discovery
| # | Model | Serving | ||||||
|---|---|---|---|---|---|---|---|---|
| 1 | Opus 5 | 39.98 | 14.80 | 7.19 | 13.05 | 86.64 | $4.14 | API |
| 2 | GPT-5.6 Sol | 35.38 | 15.81 | 3.16 | 13.00 | 83.19 | $2.02 | API |
| 3 | Sonnet 5 | 21.33 | 10.24 | 1.16 | 6.96 | 83.88 | $1.47 | API |
| 4 | Haiku 4.5 | 12.92 | 5.27 | 0.21 | 5.91 | 75.00 | $0.26 | API |
| 5 | gpt-oss-20b | 7.41 | 2.94 | 0.68 | 3.43 | 75.00 | $0.07 | GPU |
| 6 | Qwen3-Coder-30B | 5.90 | 3.26 | 0.14 | 1.94 | 75.00 | $0.05 | GPU |
| 7 | GLM-4-32B | 1.46 | 1.12 | 0.08 | 0.25 | 25.00 | $0.20 | GPU |
| 8 | Qwen3-8B | 1.31 | 0.70 | 0.39 | 0.22 | 30.71 | $0.22 | GPU |
| 9 | Devstral-Small | 0.81 | 0.75 | 0.06 | 0.00 | 15.00 | $0.20 | GPU |
Mean score across 20 worlds × 3 budget conditions, one replicate each. Scores are out of 100; measured ceiling = 85.5.
Qwen3-8B and GLM-4-32B ran a reduced 8,000-token output budget and are not a like-for-like comparison.
02 Disease states
Each synthetic world expresses hidden disease biology through participant-level medical data.
Preserved ejection fraction with a thickened wall and impaired filling.
03 Environment
How it works
Biobank
Genetics, omics, imaging, ECG, EHR.
Phenotype
Segment the myocardium from raw arrays, engineer features, fit a model against a proxy outcome.
Causal targets
Screen the proteome, instrument it genetically, separate drivers from decoys.
Experiments
Spend a finite research budget.
Submission
Nominate targets and therapeutic direction.
world_07/
├─ genotypes.vcf.gz
├─ proteomics.parquet
├─ transcriptomics.parquet
├─ metabolomics.parquet
├─ covariates.parquet
├─ ecg_features.parquet
├─ coronary_ct.parquet
├─ ehr_diagnoses.parquet
├─ mortality.parquet
├─ mace_events.parquet
├─ targetability.parquet
├─ imaging/
└─ imaging_visit2/The agent receives the files, writes Python, and chooses analyses and experiments over 30 turns.
04 Method
Hidden causal worlds
Each world is procedurally generated from a sealed structural causal model linking genetics, molecular measurements, hidden disease state, observable phenotypes, and intervention outcomes.
The identity and number of causal molecular drivers are hidden from the agent.
Analyses and experiments are chosen against accumulated evidence and the remaining budget.
T1 Confounding · T2 Reverse causation · T3 Selection bias · T4 Causal non-identifiability · T5 Imaging batch effects · T6 Benign remodeling · T7 Instrument pleiotropy · T8 Surrogate-outcome discordance · T9 Assay unit mixing · A9 Slow effect